Safety of direct drug provocation testing in adults with penicillin allergy and association with health and economic benefits
Authors:
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 123 (5) , 468-475
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Consequences of avoiding β-lactams in patients with β-lactam allergiesJournal of Allergy and Clinical Immunology, 2016
- The prevalence and impact of antimicrobial allergies and adverse drug reactions at an Australian tertiary centreBMC Infectious Diseases, 2015
- Comparative Effectiveness of Beta-Lactams Versus Vancomycin for Treatment of Methicillin-SusceptibleStaphylococcus aureusBloodstream Infections Among 122 HospitalsClinical Infectious Diseases, 2015
- A real-time prospective evaluation of clinical pharmaco-economic impact of diagnostic label of ‘penicillin allergy’ in a UK teaching hospitalJournal of Clinical Pathology, 2014
- Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort studyJournal of Allergy and Clinical Immunology, 2014
- Penicillin Skin Testing: Potential Implications for Antimicrobial StewardshipPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- The impact of penicillin skin testing on clinical practice and antimicrobial stewardshipJournal of Hospital Medicine, 2013
- Impact of an Antimicrobial Allergy Label in the Medical Record on Clinical Outcomes in Hospitalized PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2011
- The role of penicillin in benign skin rashes in childhood: A prospective study based on drug rechallengeJournal of Allergy and Clinical Immunology, 2011
- Drug Allergy: An Updated Practice ParameterAnnals of Allergy, Asthma & Immunology, 2010